Vaccination of vampire bats using recombinant vaccinia-rabies virus. 2002

Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
Unidad de Investigación Médica en Inmunología, Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Pediatría, Av. Cuauhtemoc 330, Col. Doctores, 06725 México D.F., Mexico. aaguilas@data.net.mx

Adult vampire bats (Desmodus rotundus) were vaccinated by intramuscular, scarification, oral, or aerosol routes (n = 8 in each group) using a vaccinia-rabies glycoprotein recombinant virus. Sera were obtained before and 30 days after vaccination. All animals were then challenged intramuscularly with a lethal dose of rabies virus. Neutralizing antirabies antibodies were measured by rapid fluorescent focus inhibition test (RFFIT). Seroconversion was observed with each of the routes employed, but some aerosol and orally vaccinated animals failed to seroconvert. The highest antibody titers were observed in animals vaccinated by intramuscular and scarification routes. All animals vaccinated by intramuscular, scarification, and oral routes survived the viral challenge, but one of eight vampire bats receiving aerosol vaccination succumbed to the challenge. Of 31 surviving vaccinated and challenged animals, nine lacked detectable antirabies antibodies by RFFIT (five orally and four aerosol immunized animals). In contrast, nine of 10 non-vaccinated control bats succumbed to viral challenge. The surviving control bat had antiviral antibodies 90 days after viral challenge. These results suggest that the recombinant vaccine is an adequate and safe immunogen for bats by all routes tested.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D011818 Rabies Acute VIRAL CNS INFECTION affecting mammals, including humans. It is caused by RABIES VIRUS and usually spread by contamination with virus-laden saliva of bites inflicted by rabid animals. Important animal vectors include the dog, cat, bat, fox, raccoon, skunk, and wolf. Encephalitic Rabies,Furious Rabies,Hydrophobia,Paralytic Rabies,Lyssa,Furious Raby,Lyssas,Rabies, Encephalitic,Rabies, Furious,Raby, Furious
D011819 Rabies Vaccines Vaccines or candidate vaccines used to prevent and treat RABIES. The inactivated virus vaccine is used for preexposure immunization to persons at high risk of exposure, and in conjunction with rabies immunoglobulin, for postexposure prophylaxis. Rabies Human Diploid Cell Vaccine,Rabies Vaccine,Vaccine, Rabies,Vaccines, Rabies
D011820 Rabies virus The type species of LYSSAVIRUS causing rabies in humans and other animals. Transmission is mostly by animal bites through saliva. The virus is neurotropic multiplying in neurons and myotubes of vertebrates. Rabies viruses
D002685 Chiroptera Order of mammals whose members are adapted for flight. It includes bats, flying foxes, and fruit bats. Bats,Flying Foxes,Horseshoe Bats,Pteropodidae,Pteropus,Rhinolophus,Rousettus,Bat, Horseshoe,Bats, Horseshoe,Foxes, Flying,Horseshoe Bat
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
December 1993, The Onderstepoort journal of veterinary research,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
November 1988, The Veterinary record,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
June 2005, Epidemiology and infection,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
November 1994, Vaccine,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
January 1986, Nature,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
July 1998, Vaccine,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
December 2010, Emerging infectious diseases,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
November 1972, Journal of mammalogy,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
March 1993, Microbial releases : viruses, bacteria, fungi,
Alvaro Aguilar-Setién, and Yolanda Campos Leon, and Emiliano Cruz Tesoro, and Roberto Kretschmer, and Bernard Brochier, and Paul-Pierre Pastoret
April 1990, Vaccine,
Copied contents to your clipboard!